CD79A and Cognitive impairment: Nevertheless, in a further cohort of PD patients with and without cognitive impairment (n = 296) and controls (n = 295), the association between NMDAR IgA/IgM antibodies and the presence and severity of cognitive impairment in PD was not confirmed.